Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 11—November 2004

Research

Histopathologic Improvement with Lymphedema Management, Léogâne, Haiti

Susan F. Wilson*, Jeannette Guarner*, Alix L. Valme†, Jacky Louis-Charles†, Tara L. Jones*, and David G. Addiss*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Hôpital Ste. Croix, Léogâne, Haiti

Main Article

Figure 2

Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathology in either biopsy, and boxes with a diagonal line indicate that histopathology was observed on both initial and follow-up biopsies. Boxes with an X indicate insufficient data.

Figure 2. Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathology in either biopsy, and boxes with a diagonal line indicate that histopathology was observed on both initial and follow-up biopsies. Boxes with an X indicate insufficient data.

Main Article

TOP